AUSERN
‹ Today's brief
Trial

Virus-based therapy cuts bladder-cancer recurrence by two-thirds in a phase 3 trial

Medicine, 2 days ago

In 367 patients, those given cretostimogene after surgery had 68% fewer recurrences over a median 17 months. These are the company's own topline figures, not yet peer reviewed.

The catch

Company press release with topline results only. Seventeen months is short for a cancer that recurs over years.

Sources

  1. globenewswire.com, GlobeNewswire (primary)

Next in today's brief

ConfirmedSpaceX catches a Starship upper stage on the tower for the first time

‹ Previous storyNext story ›